Home›Stock Screener›MK Proteins›Financial Statements

MK Proteins Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, MK Proteins (MKPL) reported revenue ₹383 Cr, net profit ₹7 Cr and EPS ₹0.18, with a net profit margin of 1.8% and ROE of 9.2%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see MKPL stock price BSE.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 1.83% 2026 data
EBITDA Margin 2.87% 2026 data
Operating Margin 3.00% 2026 data
Return on Assets 5.34% 2026 data
Return on Equity 9.21% 2026 data

Balance Sheet Ratios

Current Ratio 59.00 2026 data
Equity Ratio 58.02% 2026 data
Asset Turnover 2.92 2026 data

MKPL Revenue, Net Profit & EBITDA — Year-on-Year Growth

MKPL YoY (March 2025 vs March 2026) — revenue +42.9%, net profit -12.5%, EBITDA -15.4%, expenses +45.5%. Analyse MKPL shareholding pattern to track promoter, FII and institutional holdings.

Revenue Growth
+42.9%
Year-over-Year
Net Profit Growth
-12.5%
Year-over-Year
EBITDA Growth
-15.4%
Year-over-Year
Expense Growth
+45.5%
Year-over-Year
Equity Growth
+8.6%
Year-over-Year
Operating Cash Flow Growth
-150.0%
Year-over-Year
Investing Cash Flow Growth
+66.7%
Year-over-Year
Financing Cash Flow Growth
+166.7%
Year-over-Year

MKPL Income Statement — Revenue, EBITDA & Net Profit

MK Proteins revenue ₹383 Cr, EBITDA ₹11 Cr, net profit ₹7 Cr, EPS ₹0.18 (2026) — net profit margin 1.8%. Also explore MKPL share price charts to track price trends across different timeframes.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016
Revenue 383 268 246 315 256 311 194 157 172 165 145
Expenses 371 255 229 298 240 295 189 152 166 160 141
EBITDA 11 13 17 18 16 16 5 5 6 5 4
Operating Profit Margin % 3.00% 5.00% 7.00% 5.00% 6.00% 5.00% 2.00% 3.00% 3.00% 3.00% 3.00%
Depreciation 0 0 1 1 1 1 1 1 1 1 1
Interest 2 1 1 2 1 1 2 2 2 2 2
Profit Before Tax 9 12 16 15 14 14 2 2 2 2 1
Tax 3 3 4 4 4 4 1 1 1 1 0
Net Profit 7 8 11 11 10 10 2 2 1 1 1
Earnings Per Share (₹) 0.18 0.22 0.30 0.29 8.14 24.91 4.36 4.00 3.42 4.00 3.00

MKPL Balance Sheet — Assets, Liabilities & Shareholders' Equity

MKPL total assets ₹131 Cr, total equity ₹76 Cr, total liabilities ₹ Cr (2026) — ROE 9.2%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
ASSETS
Total Assets 131 131 96 103 86 67 57 47 56 47 39
Current Assets 118 119 86 99 82 64 53 42 50 39 32
Fixed Assets 12 4 3 3 3 3 3 4 6 7 7
Capital Work in Progress 7 7 6 0 0 0 0 0 0 0 0
Investments 110 0 0 0 0 0 0 0 0 0 0
Other Assets 0 120 88 100 83 65 53 43 50 40 32
LIABILITIES
Total Liabilities
Current Liabilities 2 2 1 4 3 5 4 2 12 12 8
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 76 70 61 50 40 29 19 17 16 4 3
Share Capital 38 38 38 13 4 4 4 4 4 3 1
Reserves & Surplus 39 32 24 37 35 25 15 13 11 2 3

MKPL Cash Flow Statement — Operating, Investing & Financing

MK Proteins operating cash flow ₹-16 Cr, investing ₹-2 Cr, financing ₹18 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -16 32 -6 -10 6 -5 6 -12 -4 -4 11
Investing Activities -2 -6 0 -2 0 0 0 0 -1 -2 -1
Financing Activities 18 -27 6 12 -5 4 -7 12 5 7 -10
Net Cash Flow 0 0 0 0 0 0 0 0 0 0 0